Discussion: To explore potential interventions, a thorough literature search spanning from November 2021 to January 2024 was conducted using PubMed and Google Scholar. Articles containing keywords such as “long COVID” and “hyperbaric oxygen” were meticulously reviewed. The collated published studies, encompassing case series and randomized trials, reveal promising outcomes associated with the application of Hyperbaric Oxygen Therapy (HBO). Notably, HBO demonstrated significant improvements in patients grappling with long COVID.

Conclusion: A substantial cohort of individuals contends with the persistent effects of long COVID or post-COVID-19 syndrome, lacking effective treatment options following recovery from the acute infection. Hyperbaric Oxygen Therapy emerges as a safe treatment modality, exhibiting potential benefits for this population. Further research is warranted to delve into HBO as an adjunctive treatment for long COVID.

Introduction: Amidst the persistent global challenge of the COVID epidemic, a considerable number of patients grapple with the aftermath of their acute infection, experiencing what is commonly known as long COVID or post-COVID-19 syndrome (1). It is estimated that approximately 50 million individuals, constituting 10–20% of those initially diagnosed, endure the burdens of long COVID, with a notable impact on their health-related quality of life (2)(3). The World Health Organization characterizes long COVID as the persistence or emergence of new symptoms three months after the initial SARS-CoV-2 infection, lasting for a minimum of two months without any other explanatory factors (4).

Patients afflicted by long COVID manifest a spectrum of persistent symptoms encompassing dyspnea, cough, fatigue, cognitive impairments, anxiety, depression, sleep disturbances, palpitations, postural tachycardia syndrome (POTS), and rashes, extending beyond a 12-week period without alternative diagnostic explanations (4). Residual effects such as decreased exercise capacity, hypoxia, reduced diffusion capacity, restrictive pulmonary physiology, ground-glass opacities, fibrotic changes on imaging, thromboembolic events, hair loss, and renal impairment have been observed post-resolution of the initial COVID infection (1).

This post-COVID syndrome is a globally recognized phenomenon significantly impacting individuals’ quality of life and productivity. Despite its prevalence, there are currently no effective therapeutic interventions targeting the underlying pathophysiology of long COVID. Recent investigations, encompassing case series and randomized trials, highlight the efficacy of Hyperbaric Oxygen Therapy (HBO) in significantly improving various aspects of patients’ health, including global cognitive function, fatigue, attention, executive function, energy levels, sleep patterns, psychiatric symptoms, cardiopulmonary function, endurance, and pain. The findings suggest that HBO is not only beneficial but also a safe approach in the treatment of patients dealing with the lingering effects of long COVID.

Discussion:

Presentation and Pathophysiology of Long COVID: In a comprehensive observational cohort study spanning 38 Michigan hospitals, outcomes for 1,250 patients were assessed, revealing that 32.6% reported persistent symptoms, including dyspnea, cough, and loss of taste/smell. Factors such as age (40–54), gender (female), co-morbidities, and race (Black individuals) were identified by the CDC as increasing the risk of long COVID. The economic implications of long COVID are significant, particularly impacting those in their peak productive years.

The pathophysiology of long COVID remains elusive, exhibiting variations among individuals. Potential contributors include dysregulated T-cell activation, chronic inflammation, oxidative stress, mitochondrial dysfunction, endothelial dysfunction, thrombotic disease, tissue hypoxia, and direct brain invasion by the virus. A prospective study revealed increased levels of activated monocytes and plasmacytoid dendritic cells in individuals with long COVID symptoms, with persistent elevation of type I and type III interferons, suggesting delayed resolution of inflammation. T-cell dysfunction, thyroid dysfunction, and B-cell involvement may contribute to the autoimmunity pathophysiology. Elevated IL-6 levels observed post-COVID infection contribute to inflammation and oxidative stress, creating a state of hyperinflammation.

Potential Treatment Options: Various treatments for long COVID have been explored, including anti-inflammatory agents, specific diets, cognitive-behavioral therapy, rehabilitation, and hyperbaric oxygen therapy (HBO). While no universally effective treatments have been established, targeted approaches addressing symptom categories have shown efficacy. Pharmacological options, such as β-blockers, low-dose naltrexone, and intravenous immunoglobulin, have demonstrated effectiveness in specific symptom management. Non-pharmacological interventions, including cognitive pacing, increased salt intake, compression stockings, and dietary adjustments, have been employed. Promising supplements like coenzyme Q10 and D-ribose have also shown potential benefits.

Mechanism of Action and Rationale for HBO in Long COVID: Hyperbaric Oxygen Therapy (HBO) exerts its effects through increased pressure and elevated partial pressure of oxygen. This induces the Hyperoxic-Hypoxic Paradox, leading to increased production of reactive oxygen and nitrogen species. HBO influences immune-modulatory cytokines, reducing proinflammatory cytokines and elevating anti-inflammatory cytokines. Intermittent fluctuation of oxygen levels induces oxidative stress scavenger transcription factors, enhancing antioxidant enzyme production.

Mitigating dysregulated T-cell activation, chronic inflammation, and oxidative stress, HBO positively impacts mitochondrial function, reducing overall reactive oxygen species levels. HBO’s influence on stem cell mobilization inhibits abnormal activation of T lymphocytes and macrophages, decreasing proinflammatory cytokine secretion. Overall, HBO provides therapeutic benefits in long COVID by enhancing mitochondrial function, reducing inflammation, mobilizing stem cells, improving thrombotic disease, and alleviating hypoxia.

Numerous studies investigating the use of Hyperbaric Oxygen Therapy (HBO) in patients with long COVID syndrome have yielded promising results. A meticulous literature search from November 2021 to January 2024 revealed significant findings.

1. A trial involving six long COVID patients treated with HBO demonstrated improvement in all patients, with 5 out of 6 returning to pre-infection levels. Dyspnea symptoms, initially moderate, significantly reduced after 15 to 29 HBO treatments (22).
2. A case series of 10 patients treated with HBO reported statistically significant improvements in fatigue, global cognition, executive function, attention, information processing speed, and verbal function, with no adverse effects noted (23).
3. Zilberman-Itskovich et al. conducted a randomized, sham-controlled trial with 73 patients receiving HBO treatments for 40 sessions. Significant improvements were observed in global cognitive function, attention, executive function, energy, sleep, psychiatric symptoms, and pain. Brain MRI indicated improved perfusion and microstructural changes, suggesting HBO’s impact on inducing neuroplasticity (24)(25).
4. The ongoing Swedish study HOT-LoCO reported an interim safety report, indicating mostly mild adverse events, supporting the safe utilization of HBO in long COVID patients; however, outcome measures are pending (26).
5. A randomized, sham-controlled trial on cardiac dysfunction in long COVID patients showed that HBO significantly increased global longitudinal strain (GLS), enhancing left ventricular systolic function recovery (27).
6. A trial evaluating oxy-inflammation biomarkers in long COVID subjects treated with HBO demonstrated a reduction in reactive oxygen species (ROS), lipid peroxidation, DNA damage, nitric oxide metabolites, and inflammatory biomarkers, suggesting HBO’s potential to mitigate COVID-19-induced inflammation (28).
7. A prospective trial in 2022 treated 31 patients with 15 HBO sessions, reporting significant and sustained improvement in quality of life, endurance, strength, spirometry parameters, and cognitive functions (29).
8. A case report of a 55-year-old male undergoing HBO with pre and post-perfusion MRI demonstrated significant improvements in brain perfusion, white matter brain microstructure, and cognitive and cardiopulmonary function (30).

Overall, these studies provide substantial evidence supporting the efficacy and safety of Hyperbaric Oxygen Therapy as a potential treatment for long COVID, addressing a spectrum of symptoms and improving patients’ quality of life.

Conclusion:

Long COVID presents substantial challenges, particularly affecting individuals in their economically productive years. The accumulated evidence from eight published studies underscores the significant positive impact of Hyperbaric Oxygen Therapy (HBO) on patients diagnosed with long COVID. Currently, there are no alternative treatment options demonstrating similar efficacy in symptom improvement.

HBO emerges as a direct and comprehensive approach to addressing the multifaceted pathophysiology of long COVID, targeting chronic inflammation, small vessel injury, disrupted neural pathways, and mitochondrial dysfunction. The studies reviewed consistently highlight HBO’s potential to enhance the lives of those grappling with the lingering effects of long COVID.

Notably, HBO has proven to be a safe intervention for patients with long COVID, further supporting its potential as an adjunctive treatment. The mounting body of evidence advocates for the continued exploration of HBO as a viable and beneficial therapeutic option for individuals suffering from long COVID symptoms.

In conclusion, the current literature strongly suggests that HBO may offer significant benefits to those affected by long COVID, addressing a spectrum of symptoms and potentially improving overall quality of life. Continued research and exploration of HBO as an adjunctive treatment for long COVID are warranted to further validate its efficacy and refine its application in clinical practice.

Welcome to the Healtho2.com newsletter, your weekly guide to the latest breakthroughs in investing in longevity biotechnology. In this edition, we delve into the accelerating strides made in biotechnology, offering a glimpse into the transformative landscape that promises to extend healthy lifespans. Healtho2.com is at the forefront of this exciting journey, ensuring you stay informed about the groundbreaking developments in the biotech sector and the significant investment opportunities it presents.

Decoding the Biology of Aging:

Healtho2.com recognizes the malleability of aging as a biological process and the potential it holds for transformative interventions. Scientists have been actively engaged in manipulating aging processes since the 90s, and today, Healtho2.com is committed to bringing you the latest advancements in this frontier.

Venturing into Longevity Biotech:

Our newsletter sheds light on a growing number of biotechnology startups dedicated to therapies targeting biological aging. Some of these innovative treatments are already in clinical trials, symbolizing a future where age reversal may become a reality. Healtho2.com is your guide through this exciting journey, exploring the potential of these therapies to revolutionize healthcare and extend human lifespans.

Investing in the Fountain of Youth:

Healtho2.com recognizes the monumental investment potential in longevity biotechnology. Billionaires like Jim Mellon have referred to it as a “money fountain,” and visionary investors such as Jeff Bezos, Peter Thiel, Vinod Khosla, and Marc Andreessen have already taken strategic positions in this evolving market. Our newsletter provides insights into the investment landscape, helping you navigate the possibilities and seize opportunities in this transformative field.

Rejuvenation as the Future of Medicine:

As the longevity biotechnology landscape evolves, Healtho2.com emphasizes the emergence of rejuvenation as a pivotal focus in the future of medicine. Beyond scientific breakthroughs, this paradigm shift holds the promise of a healthier and longer life for individuals worldwide.

Explore with Healtho2.com:

For those eager to delve into the world of longevity biotechnology and explore investment opportunities, connect with us at Healtho2.com. Reach out for more information at +1 (916) 912-3214. Our dedicated professionals are ready to provide valuable insights into the latest developments, potential investment strategies, and the evolving landscape of longevity science.

Conclusion:

Healtho2.com is your trusted partner in navigating the longevity biotechnology revolution. With a commitment to keeping you informed about the latest advancements and investment opportunities, our newsletter ensures you stay ahead in the transformative journey into the future of medicine. Explore the frontier of longevity biotech with Healtho2.com.

In a recent interview with HCPLive, Dr. Shai Efrati, MD, PhD, the co-Founder and Chair of Aviv Scientific’s Medical Advisory Board, discussed a groundbreaking study that unveils the potential of hyperbaric oxygen therapy (HBOT) in providing relief for fibromyalgia induced by traumatic brain injury. As the Founder and Director of the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, Dr. Efrati sheds light on the promising results of his team’s research, offering new hope for those suffering from fibromyalgia.

The Journey from Pilot Study to Fibromyalgia Treatment:

Dr. Efrati’s journey began a decade ago with a pilot study that demonstrated the efficacy of hyperbaric oxygen therapy in eliminating fibromyalgia symptoms. Recognizing fibromyalgia as a central sensitization syndrome linked to brain signal interpretation issues, the team explored regenerating damaged brain tissue. Building on classical indications like stroke and multi-brain injuries, they developed a unique protocol of HBOT triggering stem cell replication, generating new blood vessels, and activating repair mechanisms in the brain.

Evaluating the Efficacy:

Fibromyalgia and Hyperbaric Oxygen Therapy: The recent study focused on evaluating the efficacy of HBOT in patients with fibromyalgia induced by brain injuries. The team randomized patients into two treatment groups – one receiving traditional medications like pregabalin (Lyrica) and duloxetine (Cymbalta), and the other undergoing a dedicated protocol of hyperbaric oxygen therapy. Dr. Efrati and his team meticulously analyzed various parameters, including pain levels, quality of life, and physical performance before and after the HBOT treatment.

Promising Results:

The results revealed a significant relief of fibromyalgia symptoms in patients who underwent hyperbaric oxygen therapy. This breakthrough offers a new perspective on treating fibromyalgia, addressing the root cause induced by brain injuries through a targeted and innovative therapeutic approach.

Seeking More Information:

For individuals seeking more information about Dr. Shai Efrati’s groundbreaking research and the potential of hyperbaric oxygen therapy for fibromyalgia, a dedicated contact number is provided: +1 (916) 912-3214. This allows interested parties to connect with professionals who can provide insights into the study, the therapy, and its potential application for fibromyalgia treatment.

Conclusion:

Dr. Shai Efrati’s research presents a significant stride in the medical community’s understanding of fibromyalgia and its potential treatment through hyperbaric oxygen therapy. As promising results emerge, individuals grappling with fibromyalgia-induced by traumatic brain injury may find new hope in this innovative and effective therapeutic approach.

Hyperbaric Oxygen Therapy (HBOT) has emerged as a versatile medical intervention, gaining recognition for its effectiveness in treating various acute and chronic conditions. With 14 FDA-approved applications and over 30 conditions approved by the European Committee for Hyperbaric Medicine (ECHM), HBOT is making waves in the medical community. This article explores the working principle of HBOT, its approved applications, and the ongoing scientific studies that continue to unveil its potential benefits.

Working Principle of HBOT:

HBOT involves breathing pure oxygen in a pressurized room or chamber. The increased pressure allows the lungs to gather more oxygen, which is then dissolved in the bloodstream at higher concentrations. This elevated oxygen level in the blood has profound effects on the body’s healing processes.

FDA-Approved Conditions:

Currently, the U.S. Food and Drug Administration (FDA) has approved HBOT for 14 conditions, including decompression sickness, carbon monoxide poisoning, and chronic non-healing wounds. These approvals highlight the urgency and efficacy of HBOT in addressing life-threatening situations and promoting wound healing.

European Committee for Hyperbaric Medicine (ECHM) Approvals: In addition to the FDA, the ECHM has granted approval for over 30 conditions, expanding the scope of HBOT applications. These approvals cover a broad spectrum of ailments, from neurological disorders to chronic inflammatory conditions, showcasing the potential of HBOT as an adjuvant treatment.

Ongoing Clinical Trials:

The scientific community is actively engaged in exploring the benefits of HBOT for numerous major conditions. With hundreds of completed and ongoing clinical trials, researchers are investigating the potential of HBOT in areas such as traumatic brain injury, stroke rehabilitation, and autoimmune diseases. These studies aim to provide valuable insights into the safety and effectiveness of HBOT in diverse medical scenarios.

Contact for More Information:

For individuals seeking more information about Hyperbaric Oxygen Therapy and its potential applications, the contact number is +1 (916) 912-3214. This number connects individuals with professionals knowledgeable in the field, offering an opportunity to inquire about specific conditions, ongoing research, and the availability of HBOT treatments.

Conclusion:

Hyperbaric Oxygen Therapy continues to be a focal point of scientific exploration, with an increasing number of approved conditions and ongoing clinical trials. As the medical community delves deeper into the potential applications of HBOT, it becomes crucial for individuals to stay informed about this evolving field. Whether as an urgent treatment for acute pathologies or as an adjuvant therapy for chronic diseases, HBOT stands as a beacon of hope in the quest for improved medical interventions.

1. Accelerated Wound Healing: HBOT is renowned for its ability to expedite wound healing. The heightened pressure and increased oxygen levels stimulate the formation of new blood vessels and boost collagen production, which is particularly beneficial for chronic wounds like diabetic ulcers and surgical incisions.
2. Improved Cognitive Function: Studies demonstrate that HBOT enhances brain function and cognitive abilities, making it valuable for conditions such as traumatic brain injury, stroke, and cerebral palsy. Elevated oxygen levels in the bloodstream mitigate inflammation and encourage the growth of new brain cells, leading to improved memory and overall cognitive health.
3. Enhanced Athletic Performance: Increasingly, athletes leverage HBOT to optimize their performance. The enriched oxygen levels aid in improving endurance, reducing muscle fatigue, and hastening recovery post-exertion. This positions HBOT as a valuable asset for athletes striving to elevate their performance levels.
4. Treatment for Diving Injuries: HBOT serves as an effective remedy for diving-related injuries like decompression sickness and air embolism. The combination of heightened pressure and oxygen facilitates the dissolution of nitrogen bubbles that can form during dives, reducing injury risks and supporting recovery.
5. Alleviation of Chronic Illness Symptoms: HBOT has demonstrated effectiveness in alleviating symptoms associated with chronic illnesses such as fibromyalgia, multiple sclerosis, and chronic fatigue syndrome. The increased oxygen levels mitigate inflammation and enhance cellular function, leading to symptom reduction and an improved quality of life.

At the PACIFIC HYPERBARICS , we prioritize patient care and offer three HBOT chambers. If you believe you could benefit from this treatment, please contact us at 619-423-820 for more information. Our dedicated team is ready to provide guidance on how HBOT may be a suitable option for your health needs.

In the high-stakes world of professional sports, athletes often face the challenges of recovering from injuries, particularly those that can have lasting effects on their physical and mental well-being. Concussions, spinal injuries, and chronic pain are among the common issues that athletes grapple with, presenting a need for effective and sustainable recovery solutions.

Traditional approaches to injury management, such as surgery and medication, may not always align with an athlete’s career goals or lifestyle. In recent years, a growing number of athletes, including notable figures like Lebron James, have turned to Hyperbaric Oxygen Therapy (HBOT) as a holistic and non-invasive alternative for recovery.

The Benefits of HBOT for Athletes:

1. Concussion Recovery: Concussions are a significant concern in contact sports, with potential long-term consequences for brain health. HBOT has shown promise in aiding concussion recovery by increasing oxygen delivery to the brain. This promotes healing, reduces inflammation, and helps mitigate the effects of traumatic brain injuries.
2. Neck and Spinal Injury Management: Athletes often face injuries to the neck and spinal column, leading to chronic conditions and recurring issues like pinched nerves. HBOT’s ability to enhance blood flow and oxygenation supports the healing process, potentially reducing the frequency and severity of such injuries.
3. Chronic Pain Reduction: Many athletes endure chronic pain resulting from injuries sustained during their careers. HBOT offers a non-pharmacological approach to pain management, minimizing the reliance on opioids and steroids. By improving oxygen supply to affected tissues, HBOT may contribute to reducing inflammation and alleviating chronic pain.
4. Muscle Recovery and Performance Optimization: Oxygen is vital for muscle recovery and overall performance. HBOT delivers high concentrations of oxygen to muscles, aiding in faster recovery after intense workouts. This can help athletes maintain peak physical condition and minimize downtime between games or training sessions.
5. Holistic Intervention: Unlike some conventional treatments that may have limitations or side effects, HBOT is a non-invasive and holistic intervention. It addresses multiple aspects of recovery, including physical and cognitive elements, contributing to a more comprehensive healing process.

Conclusion:

Hyperbaric Oxygen Therapy is emerging as a game-changer in the world of athlete recovery and injury management. Its ability to enhance oxygen delivery, reduce inflammation, and support holistic healing makes it an attractive option for athletes looking to optimize their performance and well-being. As more athletes embrace HBOT as a part of their routine, its role in sports medicine is likely to expand, offering a promising avenue for sustainable and effective recovery strategies.

George’s narrative unfolds against the backdrop of his tenure as a defensive tackle (DT) for the San Francisco 49ers during the illustrious 1981 Super Bowl season. Amid the euphoria of victory, the shadows of adversity loomed as he grappled with hydrocephalus—a condition marked by a dangerous buildup of fluid inside the skull. Gran mal seizures ensued, leading to a critical emergency brain surgery known as ventriculoperitoneal (VP) shunting.

The echoes of Super Bowl XVI had barely faded when, four months later, George faced a dire crisis. His shunt failed, catapulting him into the throes of two emergency brain surgeries within a span of 10 hours. Last rites were administered, but George’s resilience prevailed, marking the commencement of a relentless journey toward recovery.

Undeterred by the tribulations, George embarked on a courageous return to academia in 1986, determined to complete his biology degree. However, the path was fraught with further challenges. Over a ten-month period in 1987, he weathered four additional brain surgeries and numerous grand mal seizures while immersed in chemistry and physics courses. The toll on his cognitive functions manifested as severe short-term memory deficits and dyslexia, casting a formidable shadow on his academic pursuits.

The turning point in George’s odyssey arrived three years ago when he was confronted with major short-term memory issues and an early-onset diagnosis of frontal lobe dementia. Faced with the daunting prospect of four dementia medications—Arricept, Namenda, Lexapro, and Resperidol—alongside Lamictil for seizures, George sought refuge in the potential of HBOT and Omega 3 fish oil supplements.

Commencing his journey with hyperbaric oxygen treatments, George’s commitment and resilience bore fruit. Over a year ago, he made the courageous decision to discontinue all dementia medications. The culmination of his determination is marked by the completion of his 206th HBOT treatment, accompanied by a remarkable improvement of 14.7% in micro-cognitive memory test scores.

George Visger’s testimonial transcends the realm of personal triumph; it stands as a beacon of hope for those navigating the intricate terrain of TBI recovery. Dr. Harch’s dedication to advancing HBOT as a transformative therapeutic modality finds its manifestation in George’s resilience—a saga of triumph over adversity and a testament to the unwavering spirit of the human journey.